Please login to the form below

Not currently logged in
Email:
Password:

TB

This page shows the latest TB news and features for those working in and with pharma, biotech and healthcare.

J&J expands its TB research programme

J&J expands its TB research programme

J&J expands its TB research programme. Partners with Indian groups CSIR and IMTECH to develop new treatments. ... Johnson and Johnson (J&J) has partnered with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and

Latest news

  • GSK unveils access plan for low-income countries GSK unveils access plan for low-income countries

    HIV, TB and hepatitis C drugs - "to help address the increasing burden of cancer in developing countries".

  • EU launches HIV action plan EU launches HIV action plan

    A three-year project to address the gaps and discrepancies in existing HIV, tuberculosis (TB) and viral hepatitis prevention has been launched in Europe. ... It also aims to implement a harm reduction programme as part an EU-wide strategy for the

  • UK Prix Galien opens for entries UK Prix Galien opens for entries

    The 2014 UK Prix Galien was won by Bexsero, the first ever vaccine to treat invasive meningococcal disease, and Sirturo, the first TB medication to be approved in four decades.

  • A Schengen area of healthcare A Schengen area of healthcare

    aimed at eradicating diseases such as multidrug resistant tuberculosis (MDR-TB); and to create a level playing field between member states that will allow for a cooperative response to health threats. ... For example, the spread of MDR-TB within the EU

  • Study shows Otsuka's TB drug works even in worst cases Study shows Otsuka's TB drug works even in worst cases

    While still rare, recent experience shows that XDR-TB can be a threat even in countries with sophisticated healthcare systems. ... All told, there have been 63 reported cases of XDR-TB in the US between 1993 and 2011.

More from news
Approximately 10 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • The cultural construction of illness The cultural construction of illness

    For example, in the 21st century TB is seen exclusively as an appalling condition linked with poverty, whereas in the early 19th century, fashionable metropolitans tried to cultivate a pleasingly pale

  • Reactivating drug research programmes Reactivating drug research programmes

    One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly.

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... Consider TB, for example. Clinical trials will have to take place in India and China.

  • Interview: Jane Griffiths, Janssen EMEA Interview: Jane Griffiths, Janssen EMEA

    The company also has programmes for providing not-for-profit drugs to the 40 poorest countries, particularly for HIV, as well as for TB in the near future with the development ... of its multi-resistant TB drug.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics